These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 3946944

  • 1. Cardiovascular effects of ophthalmic timolol.
    Leier CV, Baker ND, Weber PA.
    Ann Intern Med; 1986 Feb; 104(2):197-9. PubMed ID: 3946944
    [Abstract] [Full Text] [Related]

  • 2. Association between low plasma levels of ophthalmic timolol and haemodynamics in glaucoma patients.
    Nieminen T, Uusitalo H, Turjanmaa V, Bjärnhall G, Hedenström H, Mäenpää J, Ropo A, Heikkilä P, Kähönen M.
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):369-74. PubMed ID: 15912390
    [Abstract] [Full Text] [Related]

  • 3. Dynamics and kinetics of ophthalmic timolol.
    Affrime MB, Lowenthal DT, Tobert JA, Shirk J, Eidelson B, Cook T, Onesti G.
    Clin Pharmacol Ther; 1980 Apr; 27(4):471-7. PubMed ID: 7357805
    [Abstract] [Full Text] [Related]

  • 4. Drug interaction between cimetidine and timolol ophthalmic solution: effect on heart rate and intraocular pressure in healthy Japanese volunteers.
    Ishii Y, Nakamura K, Tsutsumi K, Kotegawa T, Nakano S, Nakatsuka K.
    J Clin Pharmacol; 2000 Feb; 40(2):193-9. PubMed ID: 10664926
    [Abstract] [Full Text] [Related]

  • 5. Apraclonidine hydrochloride: an evaluation of plasma concentrations, and a comparison of its intraocular pressure lowering and cardiovascular effects to timolol maleate.
    Robin AL, Coleman AL.
    Trans Am Ophthalmol Soc; 1990 Feb; 88():149-59; discussion 159-62. PubMed ID: 1982747
    [Abstract] [Full Text] [Related]

  • 6. Pharmacogenetic explanation for excessive beta-blockade following timolol eye drops. Potential for oral-ophthalmic drug interaction.
    Edeki TI, He H, Wood AJ.
    JAMA; 1990 Feb; 274(20):1611-3. PubMed ID: 7474246
    [Abstract] [Full Text] [Related]

  • 7. Interaction between timolol eyedrops and oral nicardipine or oral diltiazem in healthy Japanese subjects.
    Yatsuka YI, Tsutsumi K, Kotegawa T, Nakamura K, Nakano S, Nakatsuka K.
    Eur J Clin Pharmacol; 1998 Apr; 54(2):149-54. PubMed ID: 9626919
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the cardiovascular effects of unoprostone 0.15%, timolol 0.5% and placebo in healthy adults during exercise using a treadmill test.
    Stewart WC, Stewart JA, Crockett S, Kubilus C, Brown A, Shams N.
    Acta Ophthalmol Scand; 2002 Jun; 80(3):272-6. PubMed ID: 12059865
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the effects of aqueous and gellan ophthalmic timolol on peak exercise performance in middle-aged men.
    Dickstein K, Aarsland T.
    Am J Ophthalmol; 1996 Apr; 121(4):367-71. PubMed ID: 8604729
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular effects of ophthalmic 0.5% timolol aqueous solution and 0.1% timolol hydrogel.
    Niño J, Tahvanainen K, Uusitalo H, Turjanmaa V, Hutri-Kähönen N, Kaila T, Ropo A, Kuusela T, Kähönen M.
    Clin Physiol Funct Imaging; 2002 Jul; 22(4):271-8. PubMed ID: 12402450
    [Abstract] [Full Text] [Related]

  • 11. Plasma timolol concentrations of timolol maleate: timolol gel-forming solution (TIMOPTIC-XE) once daily versus timolol maleate ophthalmic solution twice daily.
    Shedden AH, Laurence J, Barrish A, Olah TV.
    Doc Ophthalmol; 2001 Jul; 103(1):73-9. PubMed ID: 11678162
    [Abstract] [Full Text] [Related]

  • 12. Effect of ophthalmic administration of S-596 (Arotinolol) on intraocular pressure and haemodynamics in health volunteers: comparison with timolol.
    Nakashima M, Uematsu T, Takiguchi Y, Hashimoto H, Watanabe I, Morioka S, Hibino T.
    Eur J Clin Pharmacol; 1985 Jul; 28(4):391-6. PubMed ID: 2411566
    [Abstract] [Full Text] [Related]

  • 13. Interaction of naloxone and timolol on maximal exercise capacity and the subjective perception of fatigue.
    Gullestad L, Dolva LO, Aase O, Kjekshus J.
    Int J Sports Med; 1989 Aug; 10(4):259-63. PubMed ID: 2606592
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular effects of topical beta-blockers during exercise.
    Atkins JM, Pugh BR, Timewell RM.
    Am J Ophthalmol; 1985 Feb 15; 99(2):173-5. PubMed ID: 3970121
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of two weeks of timolol maleate treatment on the normal retinal circulation.
    Grunwald JE.
    Invest Ophthalmol Vis Sci; 1991 Jan 15; 32(1):39-45. PubMed ID: 1987105
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular effects of timolol maleate, brimonidine or brimonidine/timolol maleate in concomitant therapy.
    Stewart WC, Stewart JA, Jackson AL.
    Acta Ophthalmol Scand; 2002 Jun 15; 80(3):277-81. PubMed ID: 12059866
    [Abstract] [Full Text] [Related]

  • 20. Ocular and cardiovascular response to topical carteolol 2% and timolol 0.5% in healthy volunteers.
    Brazier DJ, Smith SE.
    Br J Ophthalmol; 1988 Feb 15; 72(2):101-3. PubMed ID: 3349009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.